Showing results (271-280 of 296) with videos related to
Sort By:
Pageof 30
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1991
Structure-activity studies of new imidazolines on adrenoceptors of rat aorta and human plateletsB V Venkataraman, G Shams, A Hamada, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 1996
Diagnostic utility of tomographic myocardial perfusion imaging with technetium 99m furifosmin (Q12) compared with thallium 201: results of a phase III multicenter trialR C Hendel, M S Verani, D D Miller, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1995
Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety StudyJ Lette, J L Tatum, S Fraser, et al.Journal of Medicinal Chemistry|February 7, 1992
Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activitiesK M Markovich, V Tantishaiyakul, A Hamada, et al.Journal of Medicinal Chemistry|April 1, 1990
Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human plateletsD D Miller, A Hamada, M T Clark, et al.The Journal of Biological Chemistry|June 5, 1998
Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparationsK Liliom, D J Fischer, T Virág, et al.Biochemical Pharmacology|February 5, 2000
Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptorsR C Mehta, M M Salazar-Bookaman, R H Fertel, et al.Journal of Medicinal Chemistry|July 19, 1996
Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidineX Zhang, X T Yao, J T Dalton, et al.Molecular Pharmacology|December 18, 1998
Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypesD J Fischer, K Liliom, Z Guo, et al.Atherosclerosis|September 27, 1996
Interleukin-2 receptor-specific fusion toxin inhibits barotrauma-induced arterial atherosclerosisD D Miller, R G Bach, F O Tio, et al.Pageof 30